These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


422 related items for PubMed ID: 16600439

  • 21. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F, Król M, Kleps J, Nowak G.
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [Abstract] [Full Text] [Related]

  • 22. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA, Salerno L, Modica MN, Pittalà V, Romeo G, Amato ME, Nowak M, Bojarski AJ, Mereghetti I, Cagnotto A, Mennini T.
    J Med Chem; 2008 Aug 14; 51(15):4529-38. PubMed ID: 18598015
    [Abstract] [Full Text] [Related]

  • 23. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Aug 14; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 24. Impact of aromatic substitution on the anticonvulsant activity of new N-(4-arylpiperazin-1-yl)-alkyl-2-azaspiro[4,5]decane-1,3-dione derivatives.
    Obniska J, Kamiński K, Tatarczyńska E.
    Pharmacol Rep; 2006 Aug 14; 58(2):207-14. PubMed ID: 16702622
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J, Tatarczyńska E, Nikiforuk A, Charakchieva-Minol S, Duszyńska B.
    Pharmacol Rep; 2006 Aug 14; 58(1):107-14. PubMed ID: 16531637
    [Abstract] [Full Text] [Related]

  • 26. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 27. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
    Kossakowski J, Raszkiewicz A, Bugno R, Bojarski AJ.
    Pol J Pharmacol; 2004 Dec 16; 56(6):843-8. PubMed ID: 15662099
    [Abstract] [Full Text] [Related]

  • 28. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Santagada V, Caliendo G.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2978-82. PubMed ID: 20347301
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4.
    Perrone R, Berardi F, Colabufo NA, Leopoldo M, Tortorella V, Fornaretto MG, Caccia C, McArthur RA.
    J Med Chem; 1996 Dec 06; 39(25):4928-34. PubMed ID: 8960552
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
    Perrone R, Berardi F, Colabufo NA, Lacivita E, Larizza C, Leopoldo M, Tortorella V.
    J Pharm Pharmacol; 2005 Oct 06; 57(10):1319-27. PubMed ID: 16259761
    [Abstract] [Full Text] [Related]

  • 33. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J, Zhang H, Cai W, Yu L, Zhen X, Zhang A.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4873-80. PubMed ID: 19559623
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, physicochemical and anticonvulsant properties of new N-4-arylpiperazin-1-yl amides of (2-aza-1,3-dioxospiro[4.4]non-2-yl)- and [4.5]dec-2-yl)-propionic acid.
    Obniska J, Kaminski K, Hondo L, Zejc A.
    Arch Pharm (Weinheim); 2007 Aug 15; 340(8):404-8. PubMed ID: 17628031
    [Abstract] [Full Text] [Related]

  • 35. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ, Duszyńska B, Kołaczkowski M, Kowalski P, Kowalska T.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5863-6. PubMed ID: 15501057
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.
    Picard M, Morisset S, Cloix JF, Bizot JC, Guerin M, Beneteau V, Guillaumet G, Hevor TK.
    Neuroscience; 2010 Sep 01; 169(3):1337-46. PubMed ID: 20580787
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity.
    Czopek A, Byrtus H, Kołaczkowski M, Pawłowski M, Dybała M, Nowak G, Tatarczyńska E, Wesołowska A, Chojnacka-Wójcik E.
    Eur J Med Chem; 2010 Apr 01; 45(4):1295-303. PubMed ID: 20060623
    [Abstract] [Full Text] [Related]

  • 38. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
    Paluchowska MH, Bugno R, Duszyńska B, Tatarczyńska E, Nikiforuk A, Lenda T, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2007 Nov 15; 15(22):7116-25. PubMed ID: 17825569
    [Abstract] [Full Text] [Related]

  • 39. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P, Marciniec K, Maślankiewicz A, Satała G, Duszyńska B, Bojarski AJ, Partyka A, Jastrzębska-Więsek M, Wróbel D, Wesołowska A, Pawłowski M.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1545-56. PubMed ID: 22277589
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives.
    Kamiński K, Obniska J.
    Acta Pol Pharm; 2008 Feb 15; 65(4):457-65. PubMed ID: 19051587
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.